搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
7 小时
on MSN
Competition explodes amid weight loss drug shortage
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...
8 小时
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
1 天
Early Study Shows Weight Loss Pill Amycretin May Lead to Significant Results Compared to ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
1 天
on MSN
Here are the Medicare Part D drugs expected to face 2025 price negotiations
With prices finalized for the first 10 Medicare Part D drugs selected for the initial round of pricing negotiations, ...
1 天
15 Unhealthiest Countries in Europe
Here is our list of the 15 unhealthiest countries in Europe. Insider Monkey Score: 14.5 ...
Opinion
Kennebec Journal
1 天
Opinion
Commentary: Who’s really keeping Ozempic and Wegovy prices so high?
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
2 天
Senator Bernie Sanders grills the top executive of Novo Nordisk over high drug prices
The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.
2 天
Europe's STOXX 600 at all-time high as China-exposed firms revel in stimulus boost
Europe's STOXX 600 share index closed at a record high on Friday as companies and sectors exposed to China continued to rally ...
2 天
Bristol-Myers Squibb: Hold Rating Amid New Schizophrenia Drug Launch and Patent Expiries
Analyst Evan Seigerman from BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) and increased the price ...
BioSpace
2 天
Lilly Is Not ‘Feeling the Bern’ on Drug Prices Like Novo: Why the Double Standard?
Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...
2 天
WeightWatchers CEO Sima Sistani is leaving the company
Sima Sistani, CEO of WeightWatchers, announced her departure from the weight-loss company, which has struggled to adapt in ...
2 天
Sen. Bernie Sanders grills maker of Ozempic
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈